Behavioral Treatment and Memantine in Body Focused Repetitive Behaviors
Status:
Not yet recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
The goal of the proposed study is to compare the efficacy of behavioral treatment (BT) to
memantine, a psychopharmacological agent, for BFRBs. 28 subjects with trichotillomania (TTM)
or skin picking disorder (SPD) will receive 8 weeks of memantine treatment, followed by 8
weeks of comprehensive behavioral therapy (ComB) treatment. The hypothesis to be tested is
that behavioral therapy will be associated with superior clinical outcomes as compared to
memantine. A second hypothesis is that both memantine and behavioral therapy will demonstrate
improvement from baseline to the respective posttreatment assessment.